SPY331.39-3.11 -0.93%
DIA277.65-1.26 -0.45%
IXIC10,751.94-158.34 -1.45%

Novus Therapeutics Q1 EPS $(0.470) Up From $(0.520) YoY

Novus Therapeutics (NASDAQ:NVUS) reported quarterly losses of $(0.470) per share. This is a 9.62 percent increase over losses of $(0.520) per share from the same period last year.

Benzinga · 05/15/2020 10:31

Novus Therapeutics (NASDAQ:NVUS) reported quarterly losses of $(0.470) per share. This is a 9.62 percent increase over losses of $(0.520) per share from the same period last year.